from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0469/umaA

LFCtreatmentdescriptionclass of inhibitor

1.186

Amikacinug/mL Amikacintranslation

1.845

Cap5-10ug/mL Capreomycintranslation

1.377

Rox10-50 ug/mL Roxithromycintranslation

1.464

SM2-5 ug/mL Streptomycintranslation

1.106

Tet5-10 ug/mL Tetracyclinetranslation

-0.293

Rif0.2-5ug/mL Rifampicintranscription

-0.158

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.191

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.107

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.228

CPZ10-50 ug/mL Chlorpromazinerespiration

0.611

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.230

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.523

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.998

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.132

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.162

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.835

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.043

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.819

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.069

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.193

KCN5-20 ug/mL Potassium cyaniderespiration

0.271

NaN30.2-2 mM Sodium aziderespiration

0.821

Nigericin50 uM Nigericinrespiration

-0.979

TRC10-150 ug/mL Triclosanrespiration

-0.057

TRZ10-25 ug/mL Thioridazinerespiration

1.050

Valinomycin0.5-10 uM Valinomycinrespiration

0.568

ZnSO42 mM ZnSO4respiration

0.449

menadione6-10 ug/mL Menadionerespiration

0.878

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.455

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.794

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.531

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.842

NRP_1Non-replicating persistence stage 1dosRassociated

0.084

Amp0.2mg/mL AmpicillincellWall

0.010

Cephalexin20-100 ug/mL CephalexincellWall

0.606

Cerulenin0.32-5 ug/mL CerulenincellWall

0.674

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.396

EMB10-20 ug/mL EthambutolcellWall

0.339

Eta12-40 ug/mL EthionamidecellWall

0.668

INH0.2-0.4 ug/mL IsoniazidcellWall

0.403

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.441

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.084

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.425

BZA0.12 mg/mL BenzamidearomaticAmides

-1.555

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.727

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.168

H2O24 mM hydrogen peroxideDNAdamaging

-0.080

Levo10 ug/mL LevofloxacinDNAdamaging

0.274

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.051

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.142

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.128

UVUV-irradiationDNAdamaging

0.682

ARP41-4 ug/mL Antitubercular compound ARP4?

0.071

Antimycin12.5-50 ug/mL Antimycin A?

0.281

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.383

PA_110-50 ug/mL Antitubercular compound PA-1?

0.671

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.963

PA8240.2-2 ug/mL PA-824?

0.540

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.049

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.553

Verapamil50 uM Verapamil?

0.247

mercaptoethanol2 mM 2-Mercaptoethanol?

0.151

methoxatin10-20 ug/mL Methoxatin?